KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Interest & Investment Income (2016 - 2025)

Acadia Pharmaceuticals has reported Interest & Investment Income over the past 16 years, most recently at $8.3 million for Q4 2025.

  • Quarterly results put Interest & Investment Income at $8.3 million for Q4 2025, up 18.91% from a year ago — trailing twelve months through Dec 2025 was $31.7 million (up 24.61% YoY), and the annual figure for FY2025 was $31.7 million, up 24.61%.
  • Interest & Investment Income for Q4 2025 was $8.3 million at Acadia Pharmaceuticals, up from $8.2 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for ACAD hit a ceiling of $8.3 million in Q4 2025 and a floor of $105000.0 in Q1 2022.
  • Median Interest & Investment Income over the past 5 years was $4.3 million (2023), compared with a mean of $4.1 million.
  • Biggest five-year swings in Interest & Investment Income: plummeted 93.31% in 2021 and later skyrocketed 3519.05% in 2023.
  • Acadia Pharmaceuticals' Interest & Investment Income stood at $129000.0 in 2021, then surged by 2713.95% to $3.6 million in 2022, then surged by 31.1% to $4.8 million in 2023, then surged by 47.24% to $7.0 million in 2024, then rose by 18.91% to $8.3 million in 2025.
  • The last three reported values for Interest & Investment Income were $8.3 million (Q4 2025), $8.2 million (Q3 2025), and $7.2 million (Q2 2025) per Business Quant data.